Haijing Wei

A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Ascending Dose and Food Effect Study to Evaluate the Tolerance, Pharmacokinetics of Jaktinib, a New Selective Janus Kinase Inhibitor in Healthy Chinese Volunteers

Jingrui Liu, Binhua Lv, Hewen Yin et al. · Frontiers in Pharmacology · 2020 · 28 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +11

Evaluation of Tolerability, Pharmacokinetics and Pharmacodynamics of Vicagrel, a Novel P2Y12 Antagonist, in Healthy Chinese Volunteers

Xiaojiao Li, Cai Liu, Xiaoxue Zhu et al. · Frontiers in Pharmacology · 2018 · 21 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +12

Tolerance, variability, and pharmacokinetics of bevacizumab biosimilars in Chinese healthy male subjects

Hong Zhang, Qingmei Li, Xiaoxue Zhu et al. · Cancer Chemotherapy and Pharmacology · 2018 · 20 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

A Phase I Clinical Study Comparing the Tolerance, Immunogenicity, and Pharmacokinetics of Proposed Biosimilar BAT1806 and Reference Tocilizumab in Healthy Chinese Men

Hong Zhang, Hong Wang, Haijing Wei et al. · Frontiers in Pharmacology · 2021 · 18 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

A phase I, randomized, double-blinded, single-dose study evaluating the pharmacokinetic equivalence of the biosimilar IBI305 and bevacizumab in healthy male subjects

Hong Zhang, Xiaoxue Zhu, Haijing Wei et al. · International Journal of Clinical Pharmacology and Therapeutics · 2019 · 15 citations

Pharmacy, Pharmacokinetics, Pharmacology +13